Media Contact:
Kristina Circelli
Director of Marketing
kcircelli@mymhs.com

Mindful Health Solutions – San Francisco Welcomes Dr. Connor McCarthy for Interventional Psychiatry 

San Francisco, CA (September 2, 2025) – Connor McCarthy, MD, joins the team of experienced, exceptional leaders in interventional psychiatric services at Mindful Health Solutions – San Francisco.

A graduate of the Medical College of Wisconsin in Green Bay with experience running a successful esketamine clinic, Dr. McCarthy has witnessed firsthand how profound this innovative treatment can be in the lives of those suffering with severe depression, who are unresponsive to conventional antidepressant medications. 

At Mindful Health Solutions, he brings this passion for providing hope and support to his patients, working with them to identify their concerns and determine the best plan for treating their mental health struggles, utilizing a mix of conventional psychotropic medications, esketamine, IV ketamine therapy, and TMS therapy. 

On his decision to join Mindful Health Solutions, he states, “I was searching for a community of providers that not only has a passion for mental health, but that is at the forefront of the field. MHS … is a leader in newer methods of treatment for common treatment-resistant conditions, such as IV ketamine, esketamine, and TMS. I know how impactful these treatments can be, and I am excited to be a provider who can help expand these services to those in the San Francisco community!”

Dr. McCarthy, alongside his San Francisco colleagues, understands that mental health care is not a “one size fits all” model and looks forward to walking alongside his patients in their recovery journey. Learn more about his approach to care here. 

About Mindful Health Solutions
Mindful Health Solutions is one of the nation’s leading providers of innovative behavioral health care and is the second-largest administrator of SPRAVATO (esketamine) in the nation. At all times, we remain focused on cutting-edge interventional psychiatric research and treatment protocols such as TMS, SPRAVATO, and IV Ketamine Therapy for patients struggling with treatment-resistant depression and other psychiatric illnesses. Our experienced clinical team is dedicated to applying groundbreaking therapies supported by positive outcome data, academic rigor, and years of expertise in novel therapeutics. Outpatient clinics are located in California, Texas, and Washington. Learn more via our website.